stay up to date on the latest updates and releases from memsorb™
Halifax-based DMF Medical has received a Class II medical device license from Health Canada to sell its memsorb carbon dioxide filtration device, which has been created to improve safety for patients undergoing general anesthesia.
HALIFAX, Nova Scotia, Canada, May 2021 – DMF Medical Incorporated – a privately held medical device company is pleased to announce that it has received a Class II medical device license from Health Canada to sell its memsorb™ carbon dioxide (CO2) filtration device for general anesthesia in the Canadian market on all major platforms.
Low, minimal and metabolic anesthesia using a novel membrane technology instead of chemical absorbents for carbon dioxide removal - clinical data.
memsorb™ in vivo presentation during the 7th annual symposium on Automated Low Flow Anesthesia & Visual Drug Display Systems.